4//SEC Filing
STARR CHRISTOPHER M 4
Accession 0001437749-23-000170
CIK 0001645469other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:08 PM ET
Size
7.6 KB
Accession
0001437749-23-000170
Insider Transaction Report
Form 4
STARR CHRISTOPHER M
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-12-31−2,859→ 0 total→ Common Stock (2,859 underlying) - Exercise/Conversion
Common Stock
2022-12-31+2,859→ 15,730 total
Holdings
- 49,400(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Represents shares acquired on vesting and settlement of restricted stock units.
- [F2]49,400 shares of common stock held by the Christopher M. Starr and Sheri L. Starr Revocable Trust over which Dr. Starr serves as Trustee.
- [F3]On February 2, 2022, the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
Documents
Issuer
Monopar Therapeutics
CIK 0001645469
Entity typeother
Related Parties
1- filerCIK 0001235470
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:08 PM ET
- Size
- 7.6 KB